There are 2789 resources available
1248P - Osimertinib and crizotinib cardiotoxicity: Are real-world studies the way forward?
Presenter: Hasan Kobat
Session: ePoster Display
1249P - Pharmacokinetic and dose finding study of osimertinib in patients with impaired renal function and low body weight
Presenter: Tetsunari Hase
Session: ePoster Display
1250P - Differences of immune microenvironment among NSCLC patients with various KRAS mutation types
Presenter: Kun Wang
Session: ePoster Display
1252P - Liquid biopsy to track KRAS G12C mutation at progressive disease in patients with advanced non-small cell lung cancer (NSCLC)
Presenter: Gianluigi De Renzi
Session: ePoster Display
1184P - Necroptosis establishes an inflammatory tumor immune microenvironment acting as tumor suppressor in lung adenocarcinoma
Presenter: Fabian Allmendinger
Session: ePoster Display
1185P - Induction immunotherapy in resectable non-small cell lung cancer harboring driver mutations: A multi-center retrospective study
Presenter: Chao Zhang
Session: ePoster Display
1186P - Study on possible mechanisms of HPD associated with the amplification of chromosome 11q13 in NSCLC
Presenter: Jie Lei
Session: ePoster Display
1187P - A mutation characteristics analysis of SMARCA4defSMARCA2wt in lung cancer
Presenter: Jisheng Li
Session: ePoster Display
1188P - Concurrent chemoradiotherapy with cisplatin + S-1 for locally advanced non-small cell lung cancer: IPD meta-analysis
Presenter: Yuri Taniguchi
Session: ePoster Display
1189P - EGFR mutation p.747_749del enhances anlotinib sensitivity by upregulating EGR1 and DUSP6 in NSCLC cells
Presenter: yu limeng
Session: ePoster Display